Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
12/29/2022
NMPA Participates in the CIMDR - GHWP Session & International Drug Reg...
12/29/2022
NMPA Issues the Provisions on Facilitating Main Responsibility of MAHs...
12/29/2022
NMPA Announces Package Insert Revision of Prednisolone Inj, Pethidine ...
12/29/2022
CDE Publicizes Its Proposed List of External Clinical Experts for Pedi...
12/29/2022
Shionogi Inks Deal with Chia Tai Tianqing Pharma to Market COVID Pil...
12/28/2022
InnoCare Receives Approval of Tafasitamab in Combo with Lenalidomide f...
12/28/2022
NMPA Issues the List of Reference Formulations for GQCE Studies (62nd ...
12/28/2022
Everest Medicines Begins Operations at mRNA Vaccine Production Site in...
12/27/2022
Antengene and Merck Enter into a Global Clinical Collaboration with M...
12/27/2022
Mainland Chinese May Now Get BioNTech COVID-19 Vaccines in Hong Kong...
12/27/2022
Chinese Flock to Smuggled India-made Meds amid COVID Scare
12/27/2022
China Scraps Quarantine Rule for International Travel and Distributes ...
12/26/2022
Data Snapshot: Top Ten Chinese Pharma Outlicensing Deals by Value 2021...
12/26/2022
NHSA Announces Comprehensive Inspection of Irregular BMI Coverage Rest...
12/26/2022
Hikma and Junshi Sign Exclusive Licensing Pact for Anticancer Toripali...
12/26/2022
Deloitte: 2023 China LSHC Investment and M&A Market Outlook
12/26/2022
Two Large Out-licensing Deals Edge November Deal Values to Over $2.9B ...
12/23/2022
Beijing's Covid Wave May Have Peaked But China's Tsunami of Cases Is M...
12/23/2022
Eisai Initiates BLA Filing for Alzheimer's Drug Lecanemab in China
12/23/2022
Drug R&D and Product Registration News Digest December 2022 (3)
12/22/2022
Merck and Kelun Ink Exclusive License Pact for Seven Investigational ...
12/22/2022
NHSA: Further Reduction of Drug and Medical Consumable Prices to Secur...
12/22/2022
NMPA and Chinese Customs Issues the Announcement for Regulation of Imp...
12/22/2022
CDE Issues Two New Guidelines for Clinical Evaluation of New TCMs
12/22/2022
CDE Seeks Public Comments on the Technical Guidelines for Immunogenic ...
12/22/2022
CDE Seeks Public Comments on the Technical Guidelines for Clinical Tri...
12/21/2022
NMPA Solicits Comments on the Guidelines for the Study of Disease Natu...
12/21/2022
Shanghai Looks to Turn Pharmacies into Healthcare Service Providers
12/21/2022
XtalPi and EDDC Partner in AI-empowered Drug Discovery Program for NSC...
12/21/2022
BioNTech Sends First Batch of Vaccine to China for German Residents Th...
Page:
61
/
719
Total number of articles:
21546
:
[First]
[<<]
[59]
[60]
[61]
[62]
[63]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit